Literature DB >> 23998856

Myocardial injury secondary to ICD shocks: insights from patients with lead fracture.

Raed Abu Sham'a1, Pablo Nery, Mouhannad Sadek, Derek Yung, Calum Redpath, Mark Perrin, Bradley Sarak, David Birnie.   

Abstract

BACKGROUND: Patients who receive appropriate implantable cardioverter defibrillator (ICD) shocks have a subsequent adverse prognosis. Most data suggest that patients with inappropriate ICD shocks also have a subsequent adverse prognosis, although this is more controversial. The shocks may be an epiphenomenon, that is, a marker of underlying disease progression; however, it cannot be excluded that shocks cause direct myocardial damage. This latter question is difficult to clarify as the arrhythmia provoking the shock can also cause troponin release. Inappropriate shocks secondary to lead fracture are an ideal situation to examine this question; any troponin release in an otherwise well and hemodynamically stable patient, is likely due directly to the shocks.
METHODS: All patients with Fidelis lead fracture admitted to our institution with inappropriate shocks were included in this study. Troponin (I or T) was considered positive if the level was above the 99th percentile reference cutoff.
RESULTS: Elevated troponin levels were recorded in 16 of 22 patients (73%). Patients with elevated troponin received a higher number of shocks (20.3 ± 30.1 vs 5.3 ± 4.8, P = 0.07) compared with patients with normal troponin. Very elevated troponin levels (>0.8 mcg/L) were seen in five of 22 (22%) patients. The mean peak troponin level for these five patients was 7.06 ± 8.56 mcg/L; two patients had troponin levels that would be expected from a medium-sized myocardial infarction or severe myocarditis.
CONCLUSION: Troponin elevation occurred in the majority of our patients after inappropriate ICD discharges secondary to lead fracture. This indicates that ICD shocks can cause myocardial injury. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  ICD leads; implantable cardioverter defibrillator; inappropriate shocks; lead fracture; troponin

Mesh:

Substances:

Year:  2013        PMID: 23998856     DOI: 10.1111/pace.12263

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-Trial.

Authors:  Verena Semmler; Jürgen Biermann; Bernhard Haller; Clemens Jilek; Nikolaus Sarafoff; Carsten Lennerz; Hrvoje Vrazic; Bernhard Zrenner; Stefan Asbach; Christof Kolb
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

2.  Newly developed atrial fibrillation progresses to a more severe INTERMACS score in a patient with advanced heart failure due to dilated cardiomyopathy.

Authors:  Akihito Saito; Eisuke Amiya; Masaru Hatano; Yumiko Hosoya; Hisataka Maki; Daisuke Nitta; Shun Minatsuki; Masafumi Watanabe; Issei Komuro
Journal:  Clin Case Rep       Date:  2017-11-01

3.  Optogenetic termination of ventricular arrhythmias in the whole heart: towards biological cardiac rhythm management.

Authors:  Emile C A Nyns; Annemarie Kip; Cindy I Bart; Jaap J Plomp; Katja Zeppenfeld; Martin J Schalij; Antoine A F de Vries; Daniël A Pijnappels
Journal:  Eur Heart J       Date:  2017-07-14       Impact factor: 29.983

4.  Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.

Authors:  Usman Mustafa; Parinita Dherange; Rohit Reddy; Joseph DeVillier; Jessica Chong; Alarozia Ihsan; Ryan Jones; Narendra Duddyala; Pratap Reddy; Paari Dominic
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

5.  Optical ventricular cardioversion by local optogenetic targeting and LED implantation in a cardiomyopathic rat model.

Authors:  Emile C A Nyns; Tianyi Jin; Magda S Fontes; Titus van den Heuvel; Vincent Portero; Catilin Ramsey; Cindy I Bart; Katja Zeppenfeld; Martin J Schalij; Thomas J van Brakel; Arti A Ramkisoensing; Guoqi Zhang; René H Poelma; Balazs Ördög; Antoine A F de Vries; Daniël A Pijnappels
Journal:  Cardiovasc Res       Date:  2022-07-27       Impact factor: 13.081

6.  Ventricular arrhythmias in patients with biventricular assist devices.

Authors:  Andrew Y Lin; Hao Tran; Michela Brambatti; Eric Adler; Victor Pretorius; Travis Pollema; Jonathan C Hsu; Gregory K Feld; Kurt Hoffmayer; Frederick Han; David Krummen; Gordon Ho
Journal:  J Interv Card Electrophysiol       Date:  2019-12-14       Impact factor: 1.900

Review 7.  The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

Authors:  Nicolas Clementy; Alexandre Bodin; Arnaud Bisson; Ana-Paula Teixeira-Gomes; Sebastien Roger; Denis Angoulvant; Valérie Labas; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.